Serology tests, which detect H. pylori-specific antibodies in blood, remain a significant segment of the H. pylori test market, despite their limitations. These tests are quick, inexpensive, and require minimal patient preparation, making them popular in primary care settings. However, they cannot distinguish between active and past infections, as antibodies persist even after successful eradication. This limits their use for post-treatment monitoring but retains utility for initial screening, especially in regions where endoscopy is unavailable.

Despite these drawbacks, serology tests hold steady demand. In North America, they are often used as a preliminary screening tool before referring patients to invasive or non-invasive confirmation tests. In Latin America, where healthcare infrastructure varies, serology tests provide a scalable solution for high-volume screening. Companies like Ortho Clinical Diagnostics and Roche continue to innovate, developing rapid antibody tests with results in under 15 minutes. Market Research Future’s serology test market trends report estimates this segment will grow at a CAGR of 4.8% through 2030, driven by cost-effectiveness and ease of use.

Challenges include clinician skepticism. Many gastroenterologists prefer breath or stool tests for active infection confirmation, viewing serology as a preliminary step rather than definitive. This has slowed growth compared to non-invasive alternatives. Additionally, cross-reactivity with other bacterial infections—such as Helicobacter hepaticus—can cause false positives, requiring careful validation. Regulatory guidelines, like the CAP’s (College of American Pathologists) updated H. pylori testing protocols, now recommend combining serology with other methods for conclusive diagnosis.

Looking forward, serology tests will retain their niche as a screening tool. Partnerships between manufacturers and public health organizations could expand their use in population-based studies, tracking H. pylori prevalence over time. For firms in this segment, focusing on reducing cross-reactivity and improving labeling clarity will be key to maintaining market share. Market Research Future’s report offers insights into clinician preferences, regional adoption patterns, and strategies to enhance serology test utility, supporting informed business decisions.